The winner was Cell2B, a technology-based company that develops solutions for human organ rejection. The company was founded in 2011 and its goal is to provide a new generation of advanced therapies that can respond to needs that remain unsolved.
This company is currently preparing for the clinical trial phases in order to bring those solutions to patient care.